市場調查報告書

非類鴉片物質系止痛緩和設備的全球市場 分析與預測 (2018-2029年):用途、技術、終端用戶、競爭情形

Global Non-Opioid Pain Relief Device Market: Focus on Application, Technology, End-User, Competitive Landscape - Analysis and Forecast, 2018-2029

出版商 BIS Research Inc. 商品編碼 906896
出版日期 內容資訊 英文 230 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
非類鴉片物質系止痛緩和設備的全球市場 分析與預測 (2018-2029年):用途、技術、終端用戶、競爭情形 Global Non-Opioid Pain Relief Device Market: Focus on Application, Technology, End-User, Competitive Landscape - Analysis and Forecast, 2018-2029
出版日期: 2019年07月26日內容資訊: 英文 230 Pages
簡介

全球非類鴉片物質系止痛緩和設備市場規模在2018年估算為36億7,400萬美金,至2029年預計將達到約88億美元。

本報告提供全球非類鴉片物質系止痛緩和設備市場相關調查,市場概要,市場動態,各市場區隔 (產品、用途、終端用戶、地區)的分析與預測,及主要企業的簡介等系統性資訊。

摘要整理

第1章 市場概要

第2章 市場動態

  • 概要
  • 市場成長促進因素
  • 阻礙市場成長要素
  • 市場機會

第3章 競爭情形

  • 主要策略、發展
  • 市場佔有率分析
  • 市場佔有率分析:各國
  • 產業的魅力:波特的五力分析
  • 產業考察

第4章 全球非類鴉片物質系止痛緩和設備市場:各用途

  • 概要
  • 神經肌痛
  • 肌肉骨骼痛
  • 外傷
  • 糖尿病神經病變
  • 其他

第5章 全球非類鴉片物質系止痛緩和設備市場:各技術

  • 概要
  • 電力無痛法
  • 射頻消融術
  • 其他新興技術

第6章 全球非類鴉片物質系止痛緩和設備市場:各終端用戶

  • 概要
  • 醫院
  • 疼痛管理中心
  • 居家醫療

第7章 全球非類鴉片物質系止痛緩和設備市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第8章 企業簡介

  • 概要
  • Abbott Laboratories
  • Bayer AG
  • Bioelectronics Corporation
  • Boston Scientific Corporation
  • Medtronic plc
  • Koninklijke Philips N.V.
  • NeuroMetrix Inc.
  • Nuvectra Corporation
  • OMRON
  • Stryker Corporation
  • SPR Therapeutics, LLC
  • Stimwave LLC
  • Thermotek Inc.
  • Zynex Medical

第9章 調查範圍、手法

目錄
Product Code: BH148A

Global Non-Opioid Pain Relief Device Market to Reach $8.8 Billion by 2029

Key Questions Answered in this Report:

  • What are the major non-opioid pain relief devices available within the market and what are their benefits?
  • What are the major drivers, challenges, and opportunities in the global non-opioid pain relief device market?
  • What are the key developmental strategies implemented by the key players to stand out in this market?
  • How is the industry anticipated to evolve during the forecast period?
  • Which region is expected to contribute to the highest sales of the global non-opioid pain relief device market during the forecast period?
  • What are the leading trends and consumer preferences witnessed in global non-opioid pain relief device market?

Overview of the Global Non-Opioid Pain Relief Device Market

The rising trend of sedentary lifestyle and growing geriatric population have led to the emergence of chronic pain disorders. Multiple chronic pain conditions including neurological and musculoskeletal disorders act as leading contributors for the global non-opioid pain relief device market. These factors have become the primary drivers for the non-opioid pain relief device market. The market is further expected to proliferate at a rapid pace owing to the increased side effects of opioid medications for pain management, that further promote the early adoption of non-opioid pain relief medical devices among people of all age groups. Moreover, a limited success rate of drugs targeting a specific disease is further facilitating the growth of the market.

Global Non-Opioid Pain Relief Device Market Forecast

In 2018, the global non-opioid pain relief device market was estimated to be $3,674 million and it is expected to reach a value of $8,778.9 million by the end of 2029. The market is primarily driven by increasing government regulations and higher incidences of chronic pain.

The overall global non-opioid pain relief device market has witnessed a steady growth. The market is expected to continue to grow with a CAGR of 8.26% during the forecast period. However, limited products available and limited awareness regarding them act as challenges that may affect the steady growth of the market

Expert Quote

"North America held the largest market share in 2018 and constitutes over 39.5% of the revenue share owing to increased incidences of chronic pain as well as higher proliferation of regulations and standards in different parts of the world. However, Asia-Pacific is projected to be the fastest-growing region and is anticipated to grow at a CAGR of over 9.9% from 2019 to 2029."

Scope of the Global Non-Opioid Pain Relief Device Market Report

The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and uncover some of the substantial parameters that must be taken into consideration before entering the market.

The report further takes into consideration the market dynamics and the competitive landscape along with the detailed financial and product contribution of the key players operating in the market. The Global Non-Opioid Pain Relief Device Market report is a compilation of different segments including market breakdown by application, technology, end-user, and region.

Market Segmentation

The global non-opioid pain relief device market segmentation is majorly done on the basis of application and technology. The application section was further segmented into neuromuscular, musculoskeletal, diabetic neuropathy, injuries and others. The neuromuscular segment dominated the global non-opioid pain relief device market, accounting for around 37.4% of the total market in 2018 and is anticipated to maintain its dominance throughout the forecast period. The other segments within the market are also estimated to witness steady growth rate in the forecast period due to surge in geriatric population worldwide and stringent regulations pertaining to opioid usage.

The global non-opioid pain relief device market segmentation is done on the basis of technology, and it is further segmented into Electroanalgesia, Radiofrequency Ablation and Other Emerging Technologies. The Electroanalgesia segment comprises multiple technologies and dominates the market with a share of 90.1%. The Radiofrequency ablation and other emerging technologies have a share of 9.7% and 0.2% respectively in the global non-opioid pain relief device market. The increased funding in research and development sector by leading companies and by government institutions have led to the advancement in the technologies and also in the associated market.

The global non-opioid pain relief device market segmentation by region is done into North America, Europe, APAC, Latin America and Middle East and Africa. North America dominated the global non-opioid pain relief device market accounting for 39.5% of the total market share in 2018 and is anticipated to uphold its dominance throughout the forecast period. The global non-opioid pain relief device market was estimated to have 1,452.6 million market in 2018. However, the highest growth rate of 9.9% is expected to be witnessed by the APAC region in the forecast period of 2019-2029.

Key Companies in the Global Non-Opioid Pain Relief Device Market

The key players in the global non-opioid pain relief device market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Koninklijke Philips N.V., Stryker, Nuvectra Corporation, Omron Corporation, Neurometrix, Inc, Calmare Therapeutics Incorporated, Bayer AG, Bioelectronics Corporation, Zynex Medical, SPR Therapeutics, AAND Stimwave LLC, Thermotek Inc.

Table of Contents

Executive Summary

1 Market Overview

  • 1.1 Pain Management Overview
  • 1.2 Pain Management by Usage of Opioid Drugs
  • 1.3 Pain Management by Usage of Non-Opioid Drugs and Devices
  • 1.4 Evolution of Pain Relief Devices
  • 1.5 Factors Propelling the Market Growth
  • 1.6 Classification of Non-Opioid Pain Relief Devices Market
  • 1.7 Potential Benefits and Risks of Non-Opioid Pain Relief Devices
  • 1.8 Market Limitations and Assumptions

2 Market Dynamics

  • 2.1 Overview
  • 2.2 Market Drivers
    • 2.2.1 Increase in Pain Incidences in Geriatric Population
    • 2.2.2 Advent of Sedentary Lifestyle Leading to Increased Burden of Chronic Pain
    • 2.2.3 Limited success Rate of Drugs Targeting Pain Disorders
    • 2.2.4 High Number of Side Effects of the Opioid Drugs
  • 2.3 Market Restraints
    • 2.3.1 Insufficient Number of Long-Term Clinical Studies
    • 2.3.2 Low Number of Pain Specialists Worldwide
    • 2.3.3 Burden of Product Recalls
    • 2.3.4 Limited Awareness Regarding Products Available
  • 2.4 Market Trends
    • 2.4.1 Shift of Demand Toward Wearable Technology
    • 2.4.2 Miniaturization and Technological Advancement in the Pain Relief Technologies
    • 2.4.3 Emergence of Minimally Invasive Therapies for Pain Relief
    • 2.4.4 Non-Opioid Treatment for Pain Over Opioid Therapies

3 Competitive Landscape

  • 3.1 Key Strategies and Developments
  • 3.2 Key Strategies and Developments
    • 3.2.1 Product Launches
    • 3.2.2 Collaborations, Joint Ventures, and Partnerships
    • 3.2.3 Awards and Recognitions
    • 3.2.4 Mergers and Acquisitions
  • 3.3 Market Share Analysis
    • 3.3.1 Market Share Analysis (by Company)
  • 3.4 Market Share Analysis (by Country)
  • 3.5 Industry Attractiveness (Porter's Five Forces Analysis)
    • 3.5.1 Bargaining Power of Suppliers
      • 3.5.1.1 Supplier to Firm Concentration Ratio
      • 3.5.1.2 Presence of Brands
      • 3.5.1.3 Degree of Product Differentiation
      • 3.5.1.4 Threat of Forward Integration
    • 3.5.2 Bargaining Power of Buyers
      • 3.5.2.1 Buyer to Firm Concentration Ratio
      • 3.5.2.2 Presence of Substitutes
      • 3.5.2.3 Dependence on Distribution Channels
      • 3.5.2.4 Buyer Information About Products
    • 3.5.3 Threat of New Entrants
      • 3.5.3.1 Regulatory Landscape
      • 3.5.3.2 Brand Visibility
      • 3.5.3.3 Product Differentiation
      • 3.5.3.4 Capital Investments and Funding
    • 3.5.4 Threat of Substitutes
      • 3.5.4.1 Buyers' Propensity toward Substitutes
      • 3.5.4.2 Availability of Substitutes
      • 3.5.4.3 Perceived Level of Product Differentiation
    • 3.5.5 Intensity of Competitive Rivalry
      • 3.5.5.1 Customer's Loyalty Toward the Brand Image
      • 3.5.5.2 Entry Barriers Through Innovations
      • 3.5.5.3 Power of Competitive Strategy
  • 3.6 Industry Insights
    • 3.6.1 Regulatory Organizations/ Associations/ Consortiums

4 Global Non-Opioid Pain Relief Device Market (By Application)

  • 4.1 Overview
  • 4.2 Neuromuscular Pain
  • 4.3 Musculoskeletal Pain
  • 4.4 Injuries
  • 4.5 Diabetic Neuropathy
  • 4.6 Others

5 Global Non-Opioid Pain Relief Device Market (by Technology)

  • 5.1 Overview
  • 5.2 Electroanalgesia
    • 5.2.1 Implantable Device
    • 5.2.2 Non-Implantable Device
      • 5.2.2.1 Traditional TENS
      • 5.2.2.2 Wearable TENS
      • 5.2.2.3 Others
  • 5.3 Radiofrequency Ablation
  • 5.4 Other Emerging Technologies

6 Global Non-Opioid Pain Relief Device Market (by End User)

  • 6.1 Overview
  • 6.2 Hospitals
  • 6.3 Pain Management Centers
  • 6.4 Homecare

7 Global Non-Opioid Pain Relief Device Market (by Region)

  • 7.1 Overview
  • 7.2 North America Non-Opioid Pain Relief Device Market
    • 7.2.1 North America Non-Opioid Pain Relief Device Market, 2018-2029, $Million
    • 7.2.2 North America Non-Opioid Pain Relief Device Market (by Application), 2018-2029, $Million
    • 7.2.3 North America Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
    • 7.2.4 North America Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
    • 7.2.5 North America Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
    • 7.2.6 North America Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
      • 7.2.6.1 The U.S.
      • 7.2.6.2 Canada
  • 7.3 Europe Non-Opioid Pain Relief Device Market
    • 7.3.1 Europe Non-Opioid Pain Relief Device Market, 2018-2029, $Million
    • 7.3.2 Europe Non-Opioid Pain Relief Device Market (by Application), 2018-2029, $Million
    • 7.3.3 Europe Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
    • 7.3.4 Europe Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
      • 7.3.4.1 The U.K.
      • 7.3.4.2 Germany
      • 7.3.4.3 Italy
      • 7.3.4.4 France
      • 7.3.4.5 Netherlands
      • 7.3.4.6 Spain
      • 7.3.4.7 Rest of Europe
  • 7.4 Asia Pacific Non-Opioid Pain Relief Device Market
    • 7.4.1 Asia-Pacific Non-Opioid Pain Relief Device Market, 2018-2029, $Million
    • 7.4.2 Asia-Pacific Non-Opioid Pain Relief Device Market (by Application), 2018-2029, $Million
    • 7.4.3 Asia-Pacific Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
    • 7.4.4 Asia-Pacific Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
      • 7.4.4.1 China
      • 7.4.4.2 India
      • 7.4.4.3 Japan
      • 7.4.4.4 Australia
      • 7.4.4.5 New Zealand
      • 7.4.4.6 Rest-of-Asia-Pacific
  • 7.5 Latin America Non-Opioid Pain Relief Device Market
    • 7.5.1 Latin America Non-Opioid Pain Relief Device Market, 2018-2029, $Million
    • 7.5.2 Latin America Non-Opioid Pain Relief Device Market (By Application), 2018-2029, $Million
    • 7.5.3 Latin America Non-Opioid Pain Relief Device Market (By Technology), 2018-2029, $Million
    • 7.5.4 Latin America Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
    • 7.5.5 Latin America Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
      • 7.5.5.1 Brazil
      • 7.5.5.2 Mexico
      • 7.5.5.3 Rest-of-Latin America
  • 7.6 Middle East and Africa Non-Opioid Pain Relief Device Market, 2018-2029, $Million
    • 7.6.1 Middle East and Africa Non-Opioid Pain Relief Device Market, 2018-2029, $Million
    • 7.6.2 Middle East and Africa Non-Opioid Pain Relief Device Market (By Application), 2018-2029, $Million
    • 7.6.3 Middle East and Africa Non-Opioid Pain Relief Device Market (By Technology), 2018-2029, $Million
    • 7.6.4 Middle East and Africa Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
    • 7.6.5 Middle East and Africa Non-Opioid Pain Relief Device Market (By Country), 2018-2029, $Million
      • 7.6.5.1 Kingdom of Saudi Arabia
      • 7.6.5.2 South Africa
      • 7.6.5.3 Rest-of-Middle East and Africa

8 Company Profiles

  • 8.1 Overview
  • 8.2 Abbott Laboratories
    • 8.2.1 Company Overview
    • 8.2.2 Role of Abbott Laboratories in the Global Non-Opioid Pain Relief Devices Market
    • 8.2.3 Financials
    • 8.2.4 SWOT Analysis
  • 8.3 Bayer AG
    • 8.3.1 Company Overview
    • 8.3.2 Role of Bayer AG in the Global Non-opioid pain relief device Market
    • 8.3.3 Financials
    • 8.3.4 SWOT Analysis
  • 8.4 Bioelectronics Corporation
    • 8.4.1 Company Overview
    • 8.4.2 Role of Bioelectronics Corporation in the Global Non-Opioid Pain Relief Devices Market
    • 8.4.3 Financials
    • 8.4.4 SWOT Analysis
  • 8.5 Boston Scientific Corporation
    • 8.5.1 Company Overview
    • 8.5.2 Financials
    • 8.5.3 SWOT Analysis
  • 8.6 Medtronic plc
    • 8.6.1 Company Overview
    • 8.6.2 Role of Medtronic plc in the Non-Opioid Pain Relief Devices Market
    • 8.6.3 Financials
    • 8.6.4 Key Insights about Financial Health of the Company
    • 8.6.5 SWOT Analysis
  • 8.7 Koninklijke Philips N.V.
    • 8.7.1 Company Overview
    • 8.7.2 Role of Koninklijke Philips N.V. in the Global non-opioid pain relief device Market
    • 8.7.3 Financials
    • 8.7.4 SWOT Analysis
  • 8.8 NeuroMetrix Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Role of NeuroMetrix, Inc. in the Non-Opioid Pain Relief Devices Market
    • 8.8.3 Financials
    • 8.8.4 SWOT Analysis
  • 8.9 Nuvectra Corporation
    • 8.9.1 Company Overview
    • 8.9.2 Role of Nuvectra Corporation in the Global Non-Opioid Pain relief Device Market
    • 8.9.3 Financials
    • 8.9.4 SWOT Analysis
  • 8.10 Omron Corporation
    • 8.10.1 Company Overview
    • 8.10.2 Role of Omron Corporation in the Global Non-Opioid Pain Relief Device Market
    • 8.10.3 Financials
    • 8.10.4 SWOT Analysis
  • 8.11 Stryker Corporation
    • 8.11.1 Company Overview
    • 8.11.2 Role of Stryker Corporation in the Global Non-Opioid Pain Relief Device Market
    • 8.11.3 Financials
    • 8.11.4 SWOT Analysis
  • 8.12 SPR Therapeutics, LLC
    • 8.12.1 Company Overview
    • 8.12.2 Role of SPR Therapeutics, LLC in the Global Non-Opioid Device Market
    • 8.12.3 SWOT Analysis
  • 8.13 Stimwave LLC
    • 8.13.1 Company Overview
    • 8.13.2 Role of Stimwave LLC in the Global Non-Opioid Device Market
    • 8.13.3 SWOT Analysis
  • 8.14 Thermotek Inc.
    • 8.14.1 Company Overview
    • 8.14.2 Role of Thermotek Inc. in the Global Non-Opioid Device Market
    • 8.14.3 SWOT Analysis
  • 8.15 Zynex Medical
    • 8.15.1 Company Overview
    • 8.15.2 Role of Zynex Medical in the Global Non-Opioid Device Market
    • 8.15.3 Financials
    • 8.15.4 SWOT Analysis

9 Research Scope and Methodology

  • 9.1 Report Scope
  • 9.2 Global Non-Opioid Pain Relief Device Market: Research Methodology
    • 9.2.1 Primary Data Sources
    • 9.2.2 Secondary Data Sources
    • 9.2.3 Data Triangulation
  • 9.3 Data and Prediction Modeling

List of Tables

  • Table 1: Impact of Market Drivers, 2018-2029
  • Table 2: Impact of Market Restraints, 2018-2029
  • Table 1.1: List of Non-Opioids Pain Relief Drugs*
  • Table 1.2: List of Non-Opioid Pain Relief Medical Devices*
  • Table 2.1: Global Mortality Census Post Opioid Usage Disorder (Year - 2015)
  • Table 2.2: Market Drivers: Impact Analysis
  • Table 2.3: Market Restraints: Impact Analysis
  • Table 3.1: Regulatory Bodies Related to Non-Opioid Pain Relief Devices (by Country)

List of Figures

  • Figure 1: Global Non-Opioid Pain Relief Device Market (by Application), 2018 and 2029
  • Figure 2: Global Non-Opioid Pain Relief Device Market (by Technology), 2018 and 2029
  • Figure 3: Global Non-Opioid Pain Relief Device Market (by End User), 2018 and 2029
  • Figure 4: Global Non-Opioid Pain Relief Device Market (by Region), 2019- 2029
  • Figure 5: Key Strategies Incorporated by the key Players in the Global Non-Opioid Pain Relief Device Market (January 2019 - April 2029)
  • Figure 6: Market Share Analysis for the Global Non-Opioid Pain Relief Device Market (by Company) (2018)
  • Figure 1.1: Global Non-Opioid Pain Relief Device Market, 2018-2029, $Million
  • Figure 2.1: Global Non-Opioid Pain Relief Device Market Dynamics
  • Figure 3.1: Share of Key Developments and Strategies, January 2016 -February 2019
  • Figure 3.2: Product Launches (by Company), January 2017-February 2019
  • Figure 3.3: Collaborations and Partnerships (by Company), January 2015-February 2019
  • Figure 3.4: Awards and Recognition (by Company), January 2015-February 2019
  • Figure 3.5: Mergers and Acquisitions Share (by Company), January 2015-February 2019
  • Figure 3.6: Market Share Analysis for the Global Non-Opioid Pain Relief Device Market, by Company (2018)
  • Figure 3.7: Market Share Analysis for the Global Non-Opioid Pain Relief Device Market (by Country) (2018 and 2029)
  • Figure 3.8: Industry Attractiveness (Porter's Five Forces Analysis)
  • Figure 3.9: Analysis of Bargaining Power of Suppliers, 2018 and 2029
  • Figure 3.10 : Analysis of Bargaining Power of Buyers, 2018 and 2029
  • Figure 3.11 : Analysis of Threat of New Entrants, 2018 and 2029
  • Figure 3.12 : Analysis of Threat of Substitutes, 2018 and 2029
  • Figure 3.13 : Analysis of Intensity of Competitive Rivalry, 2018 and 2029
  • Figure 4.1: Global Non-Opioid Pain Relief Device Market (By Application), 2018-2029, $Million
  • Figure 4.2: Global Non-Opioid Pain Relief Device Market (Neuromuscular Pain), 2018-2029, $Million
  • Figure 4.3: Global Non-Opioid Pain Relief Device Market (Musculoskeletal Pain), 2018-2029, $Million
  • Figure 4.4: Global Non-Opioid Pain Relief Device Market (Injuries), 2018-2029, $Million
  • Figure 4.5: Global Non-Opioid Pain Relief Device Market (Diabetic Neuropathy), 2018-2029, $Million
  • Figure 4.6: Global Non-Opioid Pain Relief Device Market (Other Pain), 2018-2029, $Million
  • Figure 5.1: Global Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
  • Figure 5.2: Global Non-Opioid Pain Relief Device Market (Electroanalgesia), 2018-2029, $Million
  • Figure 5.3: Global Non-Opioid Pain Relief Device Market (By Electroanalgesia Technology), 2018 and 2029
  • Figure 5.4: Global Non-Opioid Pain Relief Device Market (Implantable Device), 2018-2029, $Million
  • Figure 5.5: Market Share Analysis of Key Players in the Implantable Pain Relief Device Market, $Million
  • Figure 5.6: Fragmentation of Non-Implantable Electroanalgesia Technologies- TENS, 2018 and 2029
  • Figure 5.7: Global Non-Opioid Pain Relief Device Market (Traditional TENS), 2018-2029, $Million
  • Figure 5.8: Market Share Analysis of Key Players in the Traditional TENS Device Market, $Million
  • Figure 5.9: Global Non-Opioid Pain Relief Device Market (Wearable TENS), 2018-2029, $Million
  • Figure 5.10: Market Share Analysis of Key Players in the Wearable TENS Device Market, $Million
  • Figure 5.11: Global Non-Opioid Pain Relief Device Market (Others), 2018-2029, $Million
  • Figure 5.12: Global Non-Opioid Pain Relief Device Market (Radiofrequency Ablation), 2018-2029, $Million
  • Figure 5.13: Market Share Analysis of Key Players in Radiofrequency Ablation Device Market, $Million
  • Figure 5.14: Global Non-Opioid Pain Relief Device Market (Other Emerging Technologies), 2018-2029, $Million
  • Figure 6.1: Global Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
  • Figure 6.2: Global Non-Opioid Pain Relief Devices Market (by Hospitals), 2018-2029, $Million
  • Figure 6.3: Global Non-Opioid Pain Relief Devices Market (by Pain Management Centres), 2018-2029, $Million
  • Figure 6.4: Global Non-Opioid Pain Relief Devices Market (by Homecare), 2018-2029, $Million
  • Figure 7.1: Global Non-Opioid Pain Relief Device Market Scenario (by Region), 2018 and 2029, $Million
  • Figure 7.2: North America Non-Opioid Pain Relief Device Market Scenario, 2018-2029, $Million
  • Figure 7.3: North America Non-Opioid Pain Relief Device Market Scenario (By Application), 2018 and 2029, $Million
  • Figure 7.4: North America Non-Opioid Pain Relief Device Market Scenario (by Application), 2018 and 2029, $Million
  • Figure 7.5: North America Non-Opioid Pain Relief Device Market Scenario (by End User), 2018 and 2029, $Million
  • Figure 7.6: North America Non-Opioid Pain Relief Device Market Scenario (by Country), 2018 and 2029, $Million
  • Figure 7.7: U.S. Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.8: Canada Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.9: Europe Non-Opioid Pain Relief Device Market Scenario, 2018 and 2029, $Million
  • Figure 7.10: Europe Non-Opioid Pain Relief Device Market, (By Application), 2018 and 2029, $Million
  • Figure 7.11: Europe Non-Opioid Pain Relief Device Market Scenario (By Technology), 2018 and 2029, $Million
  • Figure 7.12: Europe Non-Opioid Pain Relief Device Market Scenario (by Country), 2018 and 2029, $Million
  • Figure 7.13: The U.K. - Non-Opioid Pain Relief Device Market, 2018-2029, $Million
  • Figure 7.14: Germany- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.15: Italy-Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.16: France- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.17: Netherlands- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.18: Spain- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.19: Rest of Europe Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.20: Asia-Pacific Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.21: Asia-Pacific Non-Opioid Pain Relief Device Market Scenario (by Application), 2018 and 2029, $Million
  • Figure 7.22: Asia-Pacific Non-Opioid Pain Relief Device Market Scenario (by Technology), 2018 and 2029, $Million
  • Figure 7.23: Asia-Pacific Non-Opioid Pain Relief Device Market Scenario (by Country), 2018 and 2029, $Million
  • Figure 7.24: China Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.25: India Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.26: Japan Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.27: Australia Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.28: New Zealand Non-Opioid Pain Relief Device Market, 2018-2029, $Million
  • Figure 7.29: Rest-of-Asia-Pacific Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.30: Latin America Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.31: Latin America Non-Opioid Pain Relief Device Market Scenario (by Application), 2018 and 2029, $Million
  • Figure 7.32: Latin America Non-Opioid Pain Relief Device Market (by Technology), 2018 and 2029, $Million
  • Figure 7.33: Latin America Non-Opioid Pain Relief Device Market (by End User), 2018 and 2029, $Million
  • Figure 7.34: Latin America Non-Opioid Pain Relief Device Market (By Country), 2018 and 2029, $Million
  • Figure 7.35: Brazil Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.36: Mexico Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.37: Rest-of-Latin America Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.38: Middle East and Africa Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.39: Middle East and Africa Non-Opioid Pain Relief Device Market (By Application), 2018 and 2029, $Million
  • Figure 7.40: Middle East and Africa Non-Opioid Pain Relief Device Market Scenario (By Technology), 2018 and 2029, $Million
  • Figure 7.41: Middle East and Africa Non-Opioid Pain Relief Device Market (By End-user), 2018 and 2029, $Million
  • Figure 7.42: Middle East and Africa Non-Opioid Pain Relief Device Market (by Country), 2018 and 2029, $Million
  • Figure 7.43: Kingdom of Saudi Arabia Non-Opioid Pain Relief Device Market, 2018 and 2029, $Million
  • Figure 7.44: South Africa Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 7.45: South Africa Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
  • Figure 8.1: Total Number of Companies Profiled
  • Figure 8.2: Abbott Laboratories: Overall Product Portfolio for Global Non-opioid Pain Relief Device Market
  • Figure 8.3: Abbott Laboratories: Overall Financials, 2016-2018
  • Figure 8.4: Abbott Laboratories: Revenue (by Segment), 2016-2018
  • Figure 8.5: Abbott Laboratories: Revenue (by Region), 2016-2018
  • Figure 8.6: Abbott Laboratories: R&D Expenditure, 2016-2018
  • Figure 8.7: Abbott Laboratories: SWOT Analysis
  • Figure 8.8: Bayer AG - Product Portfolio for Global Non-Opioid Pain Relief Device Market
  • Figure 8.9: Bayer AG - Overall Financials, 2016-2018
  • Figure 8.10: Bayer AG - Revenue (by Segment), 2016-2018
  • Figure 8.11: Bayer AG - Revenue (by Region), 2016-2018
  • Figure 8.12: Bayer AG - R&D Expenditure, 2016-2018
  • Figure 8.13: SWOT Analysis: Bayer AG
  • Figure 8.14: BioElectronics Corporation: Overall Product Portfolio
  • Figure 8.15: Bioelectronics Corporation - Overall Financials, 2015-2017
  • Figure 8.16: Bioelectronics Corporation: R&D Expenditure, 2015-2017
  • Figure 8.17: SWOT Analysis: Bioelectronics Corporation
  • Figure 8.18: Boston Scientific Corporation: Overall Product Portfolio
  • Figure 8.19: Boston Scientific Corporation: Overall Financials, 2016-2018
  • Figure 8.20: Boston Scientific Corporation: Revenue (by Segment), 2016-2018
  • Figure 8.21: Boston Scientific Corporation: Revenue (by Region), 2016-2018
  • Figure 8.22: Boston Scientific Corporation: R&D Expenditure, 2016-2018
  • Figure 8.23: SWOT Analysis: Boston scientific Corporation
  • Figure 8.24: Medtronic Plc: Overall Product Portfolio
  • Figure 8.25: Medtronic Plc: Overall Financials, 2016-2018
  • Figure 8.26: Medtronic plc: Revenue (by Segment), 2016-2018
  • Figure 8.27: Medtronic plc: Revenue (by Region), 2016-2018
  • Figure 8.28: Medtronic Plc: R&D Expenditure, 2016-2018
  • Figure 8.29: Medtronic plc: SWOT Analysis
  • Figure 8.30: Koninklijke Philips N.V. - Product Portfolio for Global non-opioid pain relief device Market
  • Figure 8.31: Koninklijke Philips N.V. - Overall Financials, 2016-2018
  • Figure 8.32: Koninklijke Philips N.V. - Revenue (by Segment), 2016-2018
  • Figure 8.33: Koninklijke Philips N.V. - Revenue (by Region), 2016-2018
  • Figure 8.34: Koninklijke Philips N.V. - R&D Expenditure, 2016-2018
  • Figure 8.35: SWOT Analysis - Koninklijke Philips N.V.
  • Figure 8.36: NeuroMetrix, Inc.: Overall Product Portfolio
  • Figure 8.37: Neurometrix Inc. - Overall Financials, 2016-2018
  • Figure 8.38: Neurometrix Inc.: R&D Expenditure, 2016-2018
  • Figure 8.39: SWOT Analysis: Neurometrix, Inc.
  • Figure 8.40: Nuvectra Corporation: Overall Product Portfolio
  • Figure 8.41: Neurometrix Inc. - Overall Financials, 2016-2018
  • Figure 8.42: Nuvectra Corporation: Revenue by Segment, 2016-2018
  • Figure 8.43: Nuvectra Corporation: Revenue by Region, 2016-2018
  • Figure 8.44: Nuvectra Corporation R&D Expenditure, 2016-2018
  • Figure 8.45: SWOT Analysis - Nuvectra Corporation
  • Figure 8.46: Omron Corporation - Product Portfolio for Global non-opioid pain relief device Market
  • Figure 8.47: Omron Corporation - Overall Financials, 2015-2017
  • Figure 8.48: Omron Corporation: Revenue by Segment, 2015-2017
  • Figure 8.49: Omron Corporation: Revenue by Region, 2015-2017
  • Figure 8.50: Omron Corporation: R&D Expenditure, 2015-2017
  • Figure 8.51: SWOT Analysis - Omron Corporation
  • Figure 8.52: Stryker Corporation - Product Portfolio for global non-opioid pain relief device market Market
  • Figure 8.53: Stryker Corporation - Overall Financials, 2016-2018
  • Figure 8.54: Stryker Corporation: Revenue by Segment, 2016-2018
  • Figure 8.55: Stryker Corporation - Revenue (by Region), 2016-2018
  • Figure 8.56: Stryker Corporation R&D Expenditure, 2016-2018
  • Figure 8.57: SWOT Analysis - Stryker Corporation
  • Figure 8.58: SPR Therapeutics: Overall Product Portfolio
  • Figure 8.59: SWOT Analysis - SPR Therapeutics
  • Figure 8.60: Stimwave LLC: Overall Product Portfolio
  • Figure 8.61: SWOT Analysis - Stimwave LLC
  • Figure 8.62: Thermotek Inc.: Overall Product Portfolio
  • Figure 8.63: SWOT Analysis - Thermotek Inc.
  • Figure 8.64: Zynex Medical: Overall Product Portfolio
  • Figure 8.65: Zynex Medical - Overall Financials, 2016-2018
  • Figure 8.66: Zynex Medical R&D Expenditure, 2016-2018
  • Figure 8.67: SWOT Analysis : Zynex Medical
  • Figure: 9.1: Global Non-Opioid Pain Relief Device Market
  • Figure: 9.2: Global Non- Opioid Pain Relief DeviceMarket: Research Methodology
  • Figure: 9.3: Secondary Research
  • Figure: 9.4: Data Triangulation
  • Figure: 9.5: Bottom-Up Approach
  • Figure: 9.6: Top-Down Approach
  • Figure: 9.7: Considered Factors for Data Prediction and Modelling
Back to Top